Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma

B. M. Aarts*, W. Prevoo, M. A. J. Meier, A. Bex, R. G. H. Beets-Tan, E. G. Klompenhouwer, F. M. Gomez

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objectives To assess the safety and efficacy of percutaneous microwave ablation (MWA) of histologically proven T1 renal cell carcinoma (RCC). Methods We analysed patients with a histologically proven RCC ( 3-5 were observed (2 T1a, 4 T1b, p = 0.045). Multivariable analysis showed that mR.E.N.A.L. nephrometry was independently associated with incomplete ablation (p = 0.012). Conclusion Microwave ablation is safe and effective for T1a and T1b RCC lesions with a significantly lower primary efficacy for T1b lesions.

Original languageEnglish
Pages (from-to)1025-1033
Number of pages9
JournalCardiovascular and Interventional Radiology
Volume43
Issue number7
DOIs
Publication statusPublished - Jul 2020

Keywords

  • Percutaneous thermal ablation
  • Microwave ablation
  • Renal cell carcinoma
  • Kidney
  • RADIO-FREQUENCY ABLATION
  • COLLECTING SYSTEM
  • CRYOABLATION
  • COMPLICATIONS
  • SAFETY
  • EFFICACY
  • TUMORS
  • RADIOFREQUENCY
  • COMPLEXITY
  • KIDNEY

Cite this